Estimating the NIH efficient frontier.

Area of Science:

• Biomedical research funding allocation
• Health economics
• Quantitative science policy

Background:

• National Institutes of Health (NIH) funding decisions face criticism for lacking focus on disease burden.
• Portfolio theory offers a systematic framework to align basic research investments with public health outcomes.
• Linking research funding to risk/reward trade-offs can improve the impact of biomedical investments.

Purpose of the Study:

• To apply modern portfolio theory to NIH funding allocations.
• To identify an "efficient frontier" of research funding for maximizing return on investment (ROI) in reducing Years of Life Lost (YLL).
• To assess the potential for improving research efficiency and reducing disease burden through data-driven allocation.

Main Methods:

• Utilized NIH funding data from 1965 to 2007.
• Estimated the "efficient frontier" for allocations across 7 disease-oriented NIH institutes.
• Measured ROI by subsequent impact on U.S. Years of Life Lost (YLL).

Main Results:

• NIH's current allocation strategy shows lower risk (17% less volatility) than an equal-allocation portfolio with similar expected returns.
• The estimated efficient frontier indicates potential for 89%–119% greater expected return or 22%–35% risk reduction.
• Achieving a 28%–89% greater decrease in YLL per unit risk may be possible.
• Acknowledged limitations including YLL imprecision and the statistical noise in linking basic research to YLL.

Conclusions:

• This study serves as a proof-of-concept for quantitative, objective, and transparent biomedical funding allocation.
• Applying analytical methods can enhance research outcomes and minimize unintended consequences.
• Systematic approaches to funding decisions can better achieve the NIH's mandate of reducing illness and disability burdens.